(Q37002810)

17 August 2017

1 reference

title

Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all. (English)

1 reference

17 August 2017

0 references

0 references

1 reference

van der Most RG

1

1 reference

17 August 2017

Currie AJ

series ordinal

2

1 reference

17 August 2017

Robinson BW

series ordinal

3

1 reference

17 August 2017

Lake RA

series ordinal

4

1 reference

17 August 2017

16 November 2007

1 reference

Cell Death & Differentiation

17 August 2017

1 reference

17 August 2017

15

1 reference

17 August 2017

1

1 reference

17 August 2017

13-20

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4402255

17 August 2017

0 references

cites work

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Friendly and dangerous signals: is the tissue in control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Natural endogenous adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Addicted to death: invasive cancer and the immune response to unscheduled cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Masquerader: high mobility group box-1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Cytolytic cells induce HMGB1 release from melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

High mobility group box 1 protein interacts with multiple Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Uric acid promotes tumor immune rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Tumour lysis syndrome in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The inflammasome: first line of the immune response to cell stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Gout-associated uric acid crystals activate the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Inflammatory caspases and inflammasomes: master switches of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Role of peroxide and superoxide anion during tumour cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Melphalan-induced expression of IFN-beta in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Mechanism of melphalan-induced B7-1 gene expression in P815 tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Importance of signaling via the IFN-alpha/beta receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

The DNA damage response arouses the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

IFN-dependent down-regulation of the NKG2D ligand H60 on tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

IL-17 family cytokines and the expanding diversity of effector T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

IL-23 promotes tumour incidence and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

Immunotherapy and chemotherapy--a practical partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

7 January 2021

Another detour on the Toll road to the interferon antiviral response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

7 January 2021

The inflammatory tumor microenvironment and its impact on cancer development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

7 January 2021

Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402255

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4402255

1 reference

17 August 2017

1 reference